Healthcare - Biotechnology - NASDAQ - US
$ 15.66
-5.49 %
$ 26 M
Market Cap
-2.33
P/E
BALANCE SHEET
8.52 M
ASSETS
827 K
LIABILITIES
7.69 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Cadrenal Therapeutics, Inc. Common Stock
| Current Assets | 8.49 M |
| Cash & Short-Term Investments | 8.4 M |
| Receivables | 0 |
| Other Current Assets | 89.7 K |
| Non-Current Assets | 27.1 K |
| Long-Term Investments | 0 |
| PP&E | 23.3 K |
| Other Non-Current Assets | 3.79 K |
| Current Liabilities | 827 K |
| Accounts Payable | 167 K |
| Short-Term Debt | 42.7 K |
| Other Current Liabilities | 617 K |
| Non-Current Liabilities | 0 |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | |
|---|---|---|
| ASSETS | ||
| Cash & Cash Equivalents | 8.4 | 32.6 K |
| Short Term Investments | 0 | 0 |
| Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Other Current Assets | 89.7 K | 0.7 |
| Total Current Assets | 8.5 | 0.7 |
| PP&E | 23.3 K | 44.6 K |
| Intangible Assets | 0 | 0 |
| Goodwill | 0 | 0 |
| Long Term Investments | 0 | 0 |
| Other Long Term Assets | 3.79 K | (0.5) |
| Other Assets | 0 | 0 |
| Total Assets | 8.5 | 0.8 |
| LIABILITIES | ||
| Accounts Payable | 0.2 | 0.4 |
| Short Term Debt | 42.7 K | 66 K |
| Other Current Liabilities | 84.2 K | 0.9 |
| Total Current Liabilities | 0.8 | 1.3 |
| Long Term Debt | 0 | 0.6 |
| Deferred Tax Income | 0 | 0 |
| Other Liabilities | 0 | 4.4 |
| Total Liabilities | 0.8 | 6.3 |
| EQUITY | ||
| Common Stock | 13 K | 8.19 K |
| Retained Earnings | (15.1) | (6.7) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 |
| Total Equity | 7.7 | (5.6) |
| Total Liabilities and Equity | 8.5 | 0.8 |
| SHARES OUTSTANDING | ||
| Common Shares Outstanding | 0.9 | 0.8 |